Hepatocyte-confined CRISPR/Cas9-based nanocleaver precisely eliminates viral DNA for efficient and safe treatment of hepatitis B virus infection
Huimin Kong, Chenya Zhuo, Ke Yi, Chunxiong Zheng, Rachel L. Mintz, Yeh‐Hsing Lao, Qingguo Zhong, Enguo Ju, Haixia Wang, Dan Shao, Haihua Xiao, Yu Tao, Mingqiang Li
Topics & Concepts
CRISPRCas9Genome editingBiologyPlasmidHepatitis B virusHepatocyteVirologyDNAGenetic enhancementCell biologyViral vectorGene deliveryGeneVirusGeneticsIn vitroRecombinant DNACRISPR and Genetic EngineeringRNA Interference and Gene DeliveryVibrio bacteria research studies